一个超小的核心外的化纳米粒子通过重塑抑制性黑色素瘤微环境来提高抗瘤免疫力和生存率
Gabriel De Leon1, Li Zhang1, Nabil A Siddiqui1
1Department of Radiology, Weill Cornell Medicine, New York, NY, USA.
Nature nanotechnology
|December 30, 2025
概括
超微小的二氧化纳米颗粒与素-6和PD-L1抑制相结合,可以增强抗黑色素瘤免疫力. 这种方法激活了免疫反应并重新编程了瘤微环境,改善了耐药黑色素瘤模型的存活率.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 先进的黑色素瘤治疗由于瘤免疫逃避而面临挑战.
- 目前的免疫疗法并非对所有患者都有效.
研究的目的:
- 为了研究与IL-6和PD-L1抑制结合的超微小的二氧化纳米颗粒在治疗耐性黑色素瘤的疗效.
- 阐明作用和免疫重编程的潜在机制.
主要方法:
- 利用一种高度耐药的黑色素瘤的小鼠模型.
- 系统地使用超微小的二氧化纳米颗粒,素-6 (IL-6) 和PD-L1抑制.
- 分析了免疫细胞种群,细胞因子通路 (干扰素) 和瘤微环境特征.
主要成果:
- 在抗性黑色素瘤模型中,组合疗法显著延长了生存时间.
- 观察到干扰素基因/IL-6/PD-L1轴刺激器的激活,导致一种促炎性瘤微环境.
- 通过I/II型干扰素通路证明了CD8依赖的细胞毒性和抗瘤炎症反应.
- 显示免疫抑制细胞群和受体的减少.
结论:
- 超微小的二氧化纳米颗粒可以将瘤的微环境重新编程到一种促炎状态.
- 这种组合疗法通过颠覆抑制成分,有效地克服瘤免疫逃避.
- 这些发现凸显了这个纳米粒子平台在增强抗瘤免疫力和黑色素瘤疗效方面的潜在临床实用性.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
02:40Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K